Cargando…
Cancer cachexia and anabolic interventions: a case report
BACKGROUND: Standard-of-care (SOC) cancer treatments are primarily aimed at reducing size and progression of a tumor. There is a need for successful supplemental anabolic therapies to combat cancer cachexia in addition to these SOC treatment modalities. Anabolic interventions, including testosterone...
Autores principales: | Dillon, Edgar L., Basra, Gurjot, Horstman, Astrid M., Casperson, Shanon L., Randolph, Kathleen M., Durham, William J., Urban, Randall J., Diaz-Arrastia, Concepcion, Levine, Lyuba, Hatch, Sandra S., Willis, Maurice, Richardson, Gwyn, Sheffield-Moore, Melinda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505578/ https://www.ncbi.nlm.nih.gov/pubmed/22585408 http://dx.doi.org/10.1007/s13539-012-0066-6 |
Ejemplares similares
-
A randomized trial of adjunct testosterone for cancer‐related muscle loss in men and women
por: Wright, Traver J., et al.
Publicado: (2018) -
Novel Noninvasive Breath Test Method for Screening Individuals at Risk for Diabetes
por: Dillon, E. Lichar, et al.
Publicado: (2009) -
Effects of adjunct testosterone on cardiac morphology and function in advanced cancers: an ancillary analysis of a randomized controlled trial
por: Scott, Jessica M., et al.
Publicado: (2019) -
Identification of serum biomarkers for aging and anabolic response
por: Banerjee, Camellia, et al.
Publicado: (2011) -
Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle loss
por: Sheffield-Moore, M., et al.
Publicado: (2013)